http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2300521-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2001-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3541a512de4c13739fbc4d21f5bfcd47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5215b8492cdab59410623cf19319ab19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3209db4830641cae246e90389ccd0900 |
| publicationDate | 2007-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2300521-C2 |
| titleOfInvention | Novel derivatives of mandelic acid and their using as thrombin inhibitors |
| abstract | FIELD: organic chemistry, medicine, pharmacy. n SUBSTANCE: invention relates to novel compounds chosen from the following substances: Ph-(3-Cl)-(5-OCHF 2 )-(R)-CH(OH)C(O)-Aze-Pab(OMe); Ph-(3-Cl)-(5-OCHF 2 )-(R)-CH(OH)C(O)-Aze-Pab(OH), and Ph-(3-Cl)-(5-OCHF 2 )-(R)-CH(OH)C(O)-Aze-Pab or their pharmaceutically acceptable salts. Proposed compounds inhibit thrombin and can be used in pharmaceutical composition for treatment state wherein thrombin inhibition is required. n EFFECT: valuable medicinal properties of compounds. n 16 cl, 49 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2523281-C2 |
| priorityDate | 2000-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 529.